Skip to main content
Clinical Trials/CTRI/2024/03/063796
CTRI/2024/03/063796
Not yet recruiting
Phase 2

Role of Shear wave elastography in assessment of response to neoadjuvantchemotherapy (NACT) in breast cancer patients. - NI

Tata Memorial Hospital, Parel0 sites0 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Health Condition 1: C50- Malignant neoplasm of breast
Sponsor
Tata Memorial Hospital, Parel
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Tata Memorial Hospital, Parel

Eligibility Criteria

Inclusion Criteria

  • 1\. HPR proven Operable breast cancer patients, planned for treatment (NACT \+ Surgery) in TMH
  • 2\. Age more than 18 years
  • 3\. Oligometastatic disease where treatment intent is curative

Exclusion Criteria

  • 1\. Metastatic disease
  • 2\. Cystic lesion– elastography is not useful
  • 3\. DCIS with no measurable mass on USG
  • 4\. Inflammatory breast cancer
  • 5\. Pregnancy
  • 6\. Patients whose pre chemotherapy images are incomplete
  • 7\. Treatment defaulters (Patients who refuse, delay or discontinue treatment at any
  • time point during the study) and those who receive any treatment outside TMH.

Outcomes

Primary Outcomes

Not specified

Similar Trials